Previous Close | 0.6400 |
Open | 0.6400 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.6389 - 0.6490 |
52 Week Range | 0.4300 - 3.2450 |
Volume | |
Avg. Volume | 15,667 |
Market Cap | 2.95M |
Beta (5Y Monthly) | 3.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | Aug 22, 2022 - Aug 29, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for GLUC
BENTONVILLE, AR, March 24, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") today provided the following corporate update, in response to requests from shareholders and interested parties for clarification of recent corporate events. John Fieldly, the current Chief Executive Officer of Celsius Holdings, Inc. (Celsius), Hal Kravitz, a current member of the Board of Directors of Celsius, and Gerry David, the former Chief Executive Officer of Celsius, comprised the indepen
BENTONVILLE, AR, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Fiscal 2021 Annual Report posted today at OTCMarkets.com. In fiscal 2021, Glucose Health, Inc. more than doubled gross profits, effectively doubled revenue, and achieved the unique status of a debt free, emerging growth, company. Fiscal 2021 Revenue of $953,681 vs. $480,713 for Fiscal 2020 = a 98% increase.Fiscal 2021 Gross Profit of
BENTONVILLE, AR, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") is pleased to advise that a patent application for "Compositions and Methods for Metabolic Health" was filed with the United States Trademark and Patent Office (USPTO) on December 23, 2021, on behalf of the Company. The patent filing discloses a composition of the combination of resistant dextrin, corosolic acid and chromium picolinate, in measures for maintaining and improving health by attenuat